SERA 3.19 (+1.92%)
US81749D1072• Medical Diagnostics & Research• Diagnostics & Research
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. SERA

Sera Prognostics (SERA) Competitor Comparison

We are evaluating the key criteria listed to compare Sera Prognostics (SERA) against its competitors in the Diagnostics & Research industry.

Market Capitalization

39 / 58

Gross Profits

51 / 52

Total Revenue

54 / 57

EBITDA

43 / 56

Free Cashflow

41 / 56

Quick Ratio

21 / 57

Earnings per Share

36 / 56

Dividend yield

0 / 9

Total Cash

40 / 57

Performance 3 years

13 / 58

Performance 5 years

46 / 58

Performance 10 years

42 / 58

Linearity 3 years

3 / 58

Linearity 5 years

43 / 58

Linearity 10 years

28 / 58

Total Rank

49 / 58

Dividend Rank

33 / 58

Valuation Rank

46 / 58

Piotroski Rank

45 / 58

Muliplier Rank

33 / 58

Linearity 10 years - SERA ranking 28 / 58

These are the competitors of Sera Prognostics in the industry Diagnostics & Research ranked by linearity 10 years
1. Inotiv NOTV
37.1
2. National Research NRC
36.77
3. Ortho Clinical Diagnostics Holdings OCDX
33.4
4. Guardant Health GH
10.4
5. NeoGenomics NEO
9.33
6. Olink Holding OLK
8.11
7. Anixa Biosciences ANIX
6.81
8. Fulgent Genetics FLGT
6.61
9. Neogen NEOG
6.51
10. Global Cord Blood CO
5.67
11. Qiagen QGEN
5.65
12. Illumina ILMN
5.33
13. Exact Sciences EXAS
5.29
14. Charles River Laboratories CRL
5
15. DarioHealth DRIO
4.86
16. Pacific Biosciences of California PACB
4.69
17. Syneos Health SYNH
3.71
18. Twist Bioscience TWST
3.58
19. Sotera Health SHC
3.41
20. Co-Diagnostics CODX
3.21
21. Icon ICLR
3.08
22. Enzo Biochem ENZ
3.08
23. Bioventus BVS
2.93
24. Myriad Genetics MYGN
2.91
25. CareDx CDNA
2.76
26. IQVIA Holdings IQV
2.58
27. Psychemedics PMD
2.5
28. Sera Prognostics SERA
2.36
29. Exagen XGN
2.28
30. Aspira Womens Health AWH
2.28
31. Agilent Technologies A
2.19
32. Meridian Bioscience VIVO
2.1
33. DexCom DXCM
2.08
34. MDxHealth MDXH
1.91
35. bioAffinity Technologies BIAF
1.9
36. Laboratory Corp of America Holdings LH
1.89
37. Biodesix BDSX
1.87
38. MaxCyte MXCT
1.78
39. Personalis PSNL
1.78
40. Prenetics Global PRE
1.71
41. Organovo Holdings ONVO
1.66
42. Neuronetics STIM
1.62
43. Mettler-Toledo MTD
1.61
44. Quest Diagnostics DGX
1.6
45. Trinity Biotech TRIB
1.57
46. Danaher DHR
1.53
47. Waters WAT
1.43
48. SeqLL SQL
1.42
49. Thermo Fisher Scientific TMO
1.39
50. Interpace Biosciences IDXG
1.33
51. PerkinElmer PKI
1.15
52. Precipio PRPO
1.09
53. IDEXX Laboratories IDXX
1.03
54. Heska HSKA
0.52
55. Natera NTRA
0.4
56. Lantheus Holdings LNTH
0.31
57. RadNet RDNT
0.3
58. Medpace Holdings MEDP
0.27
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.